Myriad Genetics Inc (MYGN)

Cash & Equivalents

$115.20M

Quarterly · Period ending: · USD

MYGN logo

MYGN Cash & Equivalents

Latest reported$115.20M
MYGN Quarterly Cash & Equivalents ($28.60M → $115.20M)
High-resolution chart · PNG

MYGN cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
115,200,000
124,400,000
149,600,000
145,400,000
74,400,000
91,800,000
102,400,000
99,900,000
92,400,000
96,900,000
132,100,000
76,000,000
102,800,000
53,600,000
56,900,000
110,700,000
105,200,000
165,200,000
257,400,000
295,200,000
118,400,000
148,900,000
117,000,000
118,300,000
163,700,000
121,000,000
81,200,000
89,900,000
93,200,000
84,900,000
90,600,000
93,300,000
110,900,000
97,400,000
88,700,000
87,900,000
102,400,000
123,800,000
108,100,000
86,900,000
68,500,000
120,500,000
134,700,000
87,400,000
64,100,000
55,209,000
59,709,000
69,803,000
64,800,000
85,798,000
71,599,000
84,987,000
104,073,000
112,323,000
68,423,000
95,583,000
86,352,000
104,852,000
108,848,000
62,676,000
52,681,000
67,378,000
67,669,000
123,305,000
92,840,000
102,149,000
60,431,000
91,196,000
63,510,000
200,685,000
178,985,000
230,233,000
237,734,000
142,392,000
114,575,000
107,216,000
143,432,000
194,871,000
85,868,000
88,625,000
98,573,000
106,407,000
118,582,000
38,728,000
49,509,000
48,393,000
62,516,000
65,494,000
83,983,000
46,912,000
42,464,000
48,233,000
61,603,000
80,421,000
97,027,000
48,519,000
61,066,953
58,567,795
53,207,043
47,358,334
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.